Pragmatic Trial of Messaging to Providers About Treatment of Hyperlipidemia (PROMPT-LIPID)

NACompletedINTERVENTIONAL
Enrollment

2,596

Participants

Timeline

Start Date

June 1, 2021

Primary Completion Date

June 9, 2022

Study Completion Date

September 9, 2022

Conditions
High Risk Atherosclerotic Cardiovascular Disease
Interventions
OTHER

Electronic Alert

"Providers will see an automated electronic alert for each eligible hyperlipidemia patient at high risk for future atherosclerotic CVD events. This alert will appear when the provider enters the order entry screen in the patient's medical record during the patient's first eligible outpatient visit. The alert consists of a pop up that notifies the physician that the patient is at very high risk for ASCVD events, displays the most recent cholesterol values and the patient's current lipid lowering therapy. It also includes a link to full treatment guidelines for hyperlipidemia, which includes a continuing medical education (CME) option to obtain CME credits."

Trial Locations (4)

06610

Bridgeport Hospotal, Bridgeport

06830

Greenwich Hospital, Greenwich

06510

Yale New Haven Hospital, New Haven

06511

St. Raphael's Hospital, New Haven

All Listed Sponsors
lead

Yale University

OTHER